AsOf

Recorded or changed on this day 2026-11-08

4,751–4,800 of 46,575 claims, by entity. Everything on 2026-11-08 →

valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
AstraZeneca · incorporated in · X0
AstraZeneca incorporated in: X0, claim clm_8352C183E226 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · revenue · 26,617,000,000 United States dollar
AstraZeneca revenue: 26,617,000,000 United States dollar, claim clm_85B6D134E13C · ended · superseded by clm_47272A7D1B25 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
AstraZeneca · SEC CIK · 0000901832
AstraZeneca SEC CIK: 0000901832, claim clm_8820826D4245 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · revenue · 23,002,000,000 United States dollar
AstraZeneca revenue: 23,002,000,000 United States dollar, claim clm_904F793B66AA · ended · superseded by clm_B25F0718A827 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total equity · 39,166,000,000 United States dollar
AstraZeneca total equity: 39,166,000,000 United States dollar, claim clm_91657DA81B37 · ended · superseded by clm_702A322E3B09 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · operating income · 4,114,000,000 United States dollar
AstraZeneca operating income: 4,114,000,000 United States dollar, claim clm_9CE71799FE73 · ended · superseded by clm_654CC8AE2812 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · net income · 5,961,000,000 United States dollar
AstraZeneca net income: 5,961,000,000 United States dollar, claim clm_9F87514064CD · ended · superseded by clm_DCF412B5DDDA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total assets · 96,483,000,000 United States dollar
AstraZeneca total assets: 96,483,000,000 United States dollar, claim clm_A839065669A3 · ended · superseded by clm_CD9BD69D497F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · net income · 3,293,000,000 United States dollar
AstraZeneca net income: 3,293,000,000 United States dollar, claim clm_AE6BE83BCC88 · ended · superseded by clm_9F87514064CD · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
AstraZeneca · total assets · 114,074,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · revenue · 22,465,000,000 United States dollar
AstraZeneca revenue: 22,465,000,000 United States dollar, claim clm_B25F0718A827 · ended · superseded by clm_790001197E10 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total equity · 16,669,000,000 United States dollar
AstraZeneca total equity: 16,669,000,000 United States dollar, claim clm_B272D51F85BC · ended · superseded by clm_6A3694B18261 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · net income · 3,144,000,000 United States dollar
AstraZeneca net income: 3,144,000,000 United States dollar, claim clm_B737A429D7E9 · ended · superseded by clm_F01EE117485C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total assets · 105,363,000,000 United States dollar
AstraZeneca total assets: 105,363,000,000 United States dollar, claim clm_BAB2B4420BCE · ended · superseded by clm_A839065669A3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total assets · 66,729,000,000 United States dollar
AstraZeneca total assets: 66,729,000,000 United States dollar, claim clm_BFC9DC65FD19 · ended · superseded by clm_BAB2B4420BCE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · operating income · 2,924,000,000 United States dollar
AstraZeneca operating income: 2,924,000,000 United States dollar, claim clm_CA91157E8FEC · ended · superseded by clm_D4ADC56D2F76 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
AstraZeneca · registrant name · ASTRAZENECA PLC
AstraZeneca registrant name: ASTRAZENECA PLC, claim clm_CC0A4381A0A0 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total equity · 37,058,000,000 United States dollar
AstraZeneca total equity: 37,058,000,000 United States dollar, claim clm_CC377A6E41D1 · ended · superseded by clm_91657DA81B37 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total assets · 101,119,000,000 United States dollar
AstraZeneca total assets: 101,119,000,000 United States dollar, claim clm_CD9BD69D497F · ended · superseded by clm_F05CE2B1D291 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · operating income · 5,162,000,000 United States dollar
AstraZeneca operating income: 5,162,000,000 United States dollar, claim clm_D4ADC56D2F76 · ended · superseded by clm_10DEC07C1593 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · net income · 7,041,000,000 United States dollar
AstraZeneca net income: 7,041,000,000 United States dollar, claim clm_DCF412B5DDDA · ended · superseded by clm_7F0BFE9EB1CD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · net income · 2,826,000,000 United States dollar
AstraZeneca net income: 2,826,000,000 United States dollar, claim clm_DEF1603E885B · ended · superseded by clm_194B34501880 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · revenue · 24,708,000,000 United States dollar
AstraZeneca revenue: 24,708,000,000 United States dollar, claim clm_E7354F8FC4AB · ended · superseded by clm_904F793B66AA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · net income · 115,000,000 United States dollar
AstraZeneca net income: 115,000,000 United States dollar, claim clm_F01EE117485C · ended · superseded by clm_AE6BE83BCC88 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total assets · 104,035,000,000 United States dollar
AstraZeneca total assets: 104,035,000,000 United States dollar, claim clm_F05CE2B1D291 · ended · superseded by clm_B12E0C1D9275 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · total equity · 15,638,000,000 United States dollar
AstraZeneca total equity: 15,638,000,000 United States dollar, claim clm_F30C48EE7B4A · ended · superseded by clm_515C40C5227C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AstraZeneca · operating income · 3,757,000,000 United States dollar
AstraZeneca operating income: 3,757,000,000 United States dollar, claim clm_F928384EA602 · ended · superseded by clm_7E98BE75827B · 1 source (1 primary) · conf 0.95
unverified: One source so far: shown on the record, not asserted, until a second source or a primary one confirms it.
Atlassian · subsidiary · LOOM
Atlassian subsidiary: LOOM, claim clm_39F58CD0DAF6 · new claim · 2 sources · conf 0.80
unverified: One source so far: shown on the record, not asserted, until a second source or a primary one confirms it.
Atlassian · subsidiary · Trello
Atlassian subsidiary: Trello, claim clm_61ED3616C4CB · new claim · 2 sources · conf 0.80
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · cash and equivalents · 18,234,000,000 United States dollar
AT&T cash and equivalents: 18,234,000,000 United States dollar, claim clm_007514850F59 · ended · superseded by clm_584E0FB8E96B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · net income · 13,903,000,000 United States dollar
AT&T net income: 13,903,000,000 United States dollar, claim clm_00AD0B9203E8 · ended · superseded by clm_F23D183BF0DE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · quarterly operating income · 5,388,000,000 United States dollar
AT&T quarterly operating income: 5,388,000,000 United States dollar, claim clm_00B9CE111B36 · ended · superseded by clm_19E4A6555FC9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · quarterly operating income · 7,269,000,000 United States dollar
AT&T quarterly operating income: 7,269,000,000 United States dollar, claim clm_00D9526F74CC · ended · superseded by clm_FF7C4FA26F22 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · total assets · 403,638,000,000 United States dollar
AT&T total assets: 403,638,000,000 United States dollar, claim clm_01225E890D26 · ended · superseded by clm_A34046EB7EB5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · revenue · 122,336,000,000 United States dollar
AT&T revenue: 122,336,000,000 United States dollar, claim clm_01B96A20BC77 · ended · superseded by clm_34B42B9F9C94 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · quarterly net income · 3,495,000,000 United States dollar
AT&T quarterly net income: 3,495,000,000 United States dollar, claim clm_027BF57E76D2 · ended · superseded by clm_E3CB174DD045 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · quarterly net income · 2,994,000,000 United States dollar
AT&T quarterly net income: 2,994,000,000 United States dollar, claim clm_039BE177A7D6 · ended · superseded by clm_87FABC179331 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · shares outstanding · 5,311,000,000 shares
AT&T shares outstanding: 5,311,000,000 shares, claim clm_0456F6EC2A31 · ended · superseded by clm_7EA20F36C233 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
AT&T · cash and equivalents · 10,767,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · total assets · 402,975,000,000 United States dollar
AT&T total assets: 402,975,000,000 United States dollar, claim clm_06B0CDDE2408 · ended · superseded by clm_40D887490F9F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · operating income · 11,746,000,000 United States dollar
AT&T operating income: 11,746,000,000 United States dollar, claim clm_0763BEE02EB0 · ended · superseded by clm_3A8322D38CC3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · employees · 242,000
AT&T employees: 242,000, claim clm_08F578C762A3 · ended · superseded by clm_E6C05955C194 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · quarterly operating income · 7,661,000,000 United States dollar
AT&T quarterly operating income: 7,661,000,000 United States dollar, claim clm_0909A30CC66A · ended · superseded by clm_8559983B9C24 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · total equity · 87,501,000,000 United States dollar
AT&T total equity: 87,501,000,000 United States dollar, claim clm_09E8AA679B85 · ended · superseded by clm_C4FD5423281B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · total assets · 272,315,000,000 United States dollar
AT&T total assets: 272,315,000,000 United States dollar, claim clm_0B9A63957AE7 · ended · superseded by clm_D0453D3FD9BA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · total assets · 402,853,000,000 United States dollar
AT&T total assets: 402,853,000,000 United States dollar, claim clm_0BD74C756E37 · ended · superseded by clm_C7CA7FF51BB1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · shares outstanding · 5,187,000,000 shares
AT&T shares outstanding: 5,187,000,000 shares, claim clm_0C2A20A77AD1 · ended · superseded by clm_28FA27208C73 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · total assets · 426,463,000,000 United States dollar
AT&T total assets: 426,463,000,000 United States dollar, claim clm_0C34A5BEDED1 · ended · superseded by clm_0BD74C756E37 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · total assets · 265,701,000,000 United States dollar
AT&T total assets: 265,701,000,000 United States dollar, claim clm_0C3D2A08AF69 · ended · superseded by clm_B0059A19AF92 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AT&T · quarterly revenue · 32,158,000,000 United States dollar
AT&T quarterly revenue: 32,158,000,000 United States dollar, claim clm_0C5E116342BF · ended · superseded by clm_53A775E50CC2 · 1 source (1 primary) · conf 0.95

What the statuses mean